Background: Stroke-associated pneumonia (SAP) has been implicated in the morbidity, mortality and increased medical cost after acute ischemic stroke. The annual cost of SAP during hospitalization in the United States approaches USD 459 million. The incidence and prognosis of SAP among intensive care unit (ICU) patients have not been thoroughly investigated. We reviewed the pathophysiology, microbiology, incidence, risk factors, outcomes and prophylaxis of SAP with special attention to ICU studies. Methods: To determine the incidence, risk factors and prognosis of acute SAP, PubMed was searched using the terms ‘pneumonia' AND ‘neurology intensive unit' and the MeSH terms ‘stroke' AND ‘pneumonia'. Non-English literature, case reports and chronic SAP studies were excluded. Studies were classified into 5 categories according to the setting they were performed in: neurological intensive care units (NICUs), medical intensive care units (MICUs), stroke units, mixed studies combining more than one setting or when the settings were not specified and rehabilitation studies. Results: The incidences of SAP in the following settings were: NICUs 4.1-56.6%, MICUs 17-50%, stroke units 3.9-44%, mixed studies 3.9-23.8% and rehabilitation 3.2-11%. The majority of NICU and MICU studies were heterogeneous including different neurovascular diseases, which partly explains the wide range of SAP incidence. The higher incidence in the majority of ICU studies compared to stroke units or acute floor studies is likely explained by the presence of mechanical ventilation, higher stroke severity causing higher rates of aspiration and stroke-induced immunodepression among ICU patients. The short-term mortality of SAP was increased among the mixed and stroke unit studies ranging between 10.1 and 37.3%. SAP was associated with worse functional outcome in the majority of stroke unit and floor studies. Mortality was less consistent among NICU and MICU studies. This difference could be due to the heterogeneity of ICU studies and the effect of small sample size or other independent risk factors for mortality such as the larger neurological deficit, mechanical ventilation, and age, which may simultaneously increase the risk of SAP and mortality confounding the outcomes of SAP itself. The pathophysiology of SAP is likely explained by aspiration combined with stroke-induced immunodepression through complex humeral and neural pathways that include the hypothalamic-pituitary-adrenal axis, parasympathetic and sympathetic systems. Conclusions: A unified definition of SAP, strict inclusion criteria, and the presence of a long-term follow-up need to be applied to the future prospective studies to better identify the incidence and prognosis of SAP, especially among ICU patients.

Keywords:
Acute ischemic stroke, Post-stroke pneumonia, Stroke-induced immunodepression, Stroke-associated pneumonia, Ventilator-associated pneumonia
1.
Vermeij FH, Scholte op Reimer WJ, de Man P, et al: Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey. Cerebrovasc Dis 2009;27:465-471.
2.
Roger VL, Go AS, Lloyd-Jones DM, et al: Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation 2012;125:e2-e220.
3.
Koennecke HC, Belz W, Berfelde D, et al: Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unit. Neurology 2011;77:965-972.
4.
Katzan IL, Dawson NV, Thomas CL, Votruba ME, Cebul RD: The cost of pneumonia after acute stroke. Neurology 2007;68:1938-1943.
5.
Wilson RD: Mortality and cost of pneumonia after stroke for different risk groups. J Stroke Cerebrovasc Dis 2012;21:61-67.
6.
Chamorro A, Meisel A, Planas AM, Urra X, van de Beek D, Veltkamp R: The immunology of acute stroke. Nat Rev Neurol 2012;8:401-410.
7.
Dirnagl U, Klehmet J, Braun JS, et al: Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke 2007;38:770-773.
8.
Bershad EM, Feen ES, Hernandez OH, Suri MF, Suarez JI: Impact of a specialized neurointensive care team on outcomes of critically ill acute ischemic stroke patients. Neurocrit Care 2008;9:287-292.
9.
Kwon HM, Jeong SW, Lee SH, Yoon BW: The pneumonia score: a simple grading scale for prediction of pneumonia after acute stroke. Am J Infect Control 2006;34:64-68.
10.
Teramoto S: Novel preventive and therapuetic strategy for post-stroke pneumonia. Expert Rev Neurother 2009;9:1187-1200.
11.
Hilker R, Poetter C, Findeisen N, et al: Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke 2003;34:975-981.
12.
Kasuya Y, Hargett JL, Lenhardt R, et al: Ventilator-associated pneumonia in critically ill stroke patients: frequency, risk factors, and outcomes. J Crit Care 2011;26:273-279.
13.
Horan TC, Andrus M, Dudeck MA: CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-332.
14.
Josephson SA, Moheet AM, Gropper MA, Nichols AD, Smith WS: Ventilator-associated pneumonia in a neurologic intensive care unit does not lead to increased mortality. Neurocrit Care 2010;12:155-158.
15.
Walter U, Knoblich R, Steinhagen V, Donat M, Benecke R, Kloth A: Predictors of pneumonia in acute stroke patients admitted to a neurological intensive care unit. J Neurol 2007;254:1323-1329.
16.
Huang JY, Zhang DY, Yao Y, Xia QX, Fan QQ: Training in swallowing prevents aspiration pneumonia in stroke patients with dysphagia. J Int Med Res 2006;34:303-306.
17.
Lim SH, Lieu PK, Phua SY, et al: Accuracy of bedside clinical methods compared with fiberoptic endoscopic examination of swallowing (FEES) in determining the risk of aspiration in acute stroke patients. Dysphagia 2001;16:1-6.
18.
Lakshminarayan K, Tsai AW, Tong X, et al: Utility of dysphagia screening results in predicting poststroke pneumonia. Stroke 2010;41:2849-2854.
19.
Jia YX, Sekizawa K, Ohrui T, Nakayama K, Sasaki H: Dopamine D1 receptor antagonist inhibits swallowing reflex in guinea pigs. Am J Physiol 1998;274:R76-R80.
20.
Nakagawa T, Ohrui T, Sekizawa K, Sasaki H: Sputum substance P in aspiration pneumonia. Lancet 1995;345:1447.
21.
Arai T, Yoshimi N, Fujiwara H, Sekizawa K: Serum substance P concentrations and silent aspiration in elderly patients with stroke. Neurology 2003;61:1625-1626.
22.
Chastre J, Fagon JY: Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867-903.
23.
Upadya A, Thorevska N, Sena KN, Manthous C, Amoateng-Adjepong Y: Predictors and consequences of pneumonia in critically ill patients with stroke. J Crit Care 2004;19:16-22.
24.
Weimar C, Roth MP, Zillessen G, et al: Complications following acute ischemic stroke. Eur Neurol 2002;48:133-140.
25.
Dziewas R, Ritter M, Schilling M, et al: Pneumonia in acute stroke patients fed by nasogastric tube. J Neurol Neurosurg Psychiatry 2004;75:852-856.
26.
Chamorro A, Urra X, Planas AM: Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke 2007;38:1097-1103.
27.
Howard RJ, Simmons RL: Acquired immunologic deficiencies after trauma and surgical procedures. Surg Gynecol Obstet 1974;139:771-782.
28.
Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U: Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci 2005;6:775-786.
29.
Prass K, Meisel C, Hoflich C, et al: Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 2003;198:725-736.
30.
Prass K, Braun JS, Dirnagl U, Meisel C, Meisel A: Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke 2006;37:2607-2612.
31.
Haeusler KG, Schmidt WU, Fohring F, et al: Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc Dis 2008;25:50-58.
32.
Liesz A, Hagmann S, Zschoche C, et al: The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation. Stroke 2009;40:2849-2858.
33.
Schulte-Herbruggen O, Quarcoo D, Meisel A, Meisel C: Differential affection of intestinal immune cell populations after cerebral ischemia in mice. Neuroimmunomodulation 2009;16:213-218.
34.
Vogelgesang A, Grunwald U, Langner S, et al: Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke 2008;39:237-241.
35.
Walter U, Kolbaske S, Patejdl R, et al: Insular stroke is associated with acute sympathetic hyperactivation and immunodepression. Eur J Neurol 2013;20:153-159.
36.
Marklund N, Peltonen M, Nilsson TK, Olsson T: Low and high circulating cortisol levels predict mortality and cognitive dysfunction early after stroke. J Intern Med 2004;256:15-21.
37.
Bernik TR, Friedman SG, Ochani M, et al: Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med 2002;195:781-788.
38.
Tuosto L, Cundari E, Gilardini Montani MS, Piccolella E: Analysis of susceptibility of mature human T lymphocytes to dexamethasone-induced apoptosis. Eur J Immunol 1994;24:1061-1065.
39.
Whalen MJ, Carlos TM, Clark RS, et al: The relationship between brain temperature and neutrophil accumulation after traumatic brain injury in rats. Acta Neurochir Suppl 1997;70:260-261.
40.
Dietrich WD, Chatzipanteli K, Vitarbo E, Wada K, Kinoshita K: The role of inflammatory processes in the pathophysiology and treatment of brain and spinal cord trauma. Acta Neurochir Suppl 2004;89:69-74.
41.
Takagi K, Ginsberg MD, Globus MY, Martinez E, Busto R: Effect of hyperthermia on glutamate release in ischemic penumbra after middle cerebral artery occlusion in rats. Am J Physiol 1994;267:H1770-H1776.
42.
Hajat C, Hajat S, Sharma P: Effects of poststroke pyrexia on stroke outcome: a meta-analysis of studies in patients. Stroke 2000;31:410-414.
43.
Wright WL: Sodium and fluid management in acute brain injury. Curr Neurol Neurosci Rep 2012;12:466-473.
44.
Huang WY, Weng WC, Peng TI, et al: Association of hyponatremia in acute stroke stage with three-year mortality in patients with first-ever ischemic stroke. Cerebrovasc Dis 2012;34:55-62.
45.
Martinez MA, Pena JM, Fernandez A, et al: Time course and prognostic significance of hemostatic changes in sepsis: relation to tumor necrosis factor-alpha. Crit Care Med 1999;27:1303-1308.
46.
Millns B, Gosney M, Jack CI, Martin MV, Wright AE: Acute stroke predisposes to oral gram-negative bacilli - A cause of aspiration pneumonia? Gerontology 2003;49:173-176.
47.
Gosney MA, Martin MV, Wright AE, Gallagher M: Enterobacter sakazakii in the mouths of stroke patients and its association with aspiration pneumonia. Eur J Intern Med 2006;17:185-188.
48.
Hassan A, Khealani BA, Shafqat S, et al: Stroke-associated pneumonia: microbiological data and outcome. Singapore Med J 2006;47:204-207.
49.
Kostadima E, Kaditis AG, Alexopoulos EI, Zakynthinos E, Sfyras D: Early gastrostomy reduces the rate of ventilator-associated pneumonia in stroke or head injury patients. Eur Respir J 2005;26:106-111.
50.
Yilmaz GR, Cevik MA, Erdinc FS, Ucler S, Tulek N: The risk factors for infections acquired by cerebral hemorrhage and cerebral infarct patients in a neurology intensive care unit in Turkey. Jpn J Infect Dis 2007;60:87-91.
51.
Dettenkofer M, Ebner W, Els T, et al: Surveillance of nosocomial infections in a neurology intensive care unit. J Neurol 2001;248:959-964.
52.
Westendorp WF, Nederkoorn PJ, Vermeij JD, Dijkgraaf MG, van de Beek D: Post-stroke infection: a systematic review and meta-analysis. BMC Neurol 2011;11:110.
53.
Sui R, Zhang L: Risk factors of stroke-associated pneumonia in Chinese patients. Neurol Res 2011;33:508-513.
54.
Yeh SJ, Huang KY, Wang TG, et al: Dysphagia screening decreases pneumonia in acute stroke patients admitted to the stroke intensive care unit. J Neurol Sci 2011;306:38-41.
55.
Commichau C, Scarmeas N, Mayer SA: Risk factors for fever in the neurologic intensive care unit. Neurology 2003;60:837-841.
56.
Yan F, Zhang D, Xu H, Guo H: Risk factors for fever in critically ill patients with acute new-onset stroke. Neurol Res 2008;30:394-399.
57.
Hassan AE, Chaudhry SA, Zacharatos H, et al: Increased rate of aspiration pneumonia and poor discharge outcome among acute ischemic stroke patients following intubation for endovascular treatment. Neurocrit Care 2012;16:246-250.
58.
Yang CC, Shih NC, Chang WC, Huang SK, Chien CW: Long-term medical utilization following ventilator-associated pneumonia in acute stroke and traumatic brain injury patients: a case-control study. BMC Health Serv Res 2011;11:289.
59.
Broadley S, Croser D, Cottrell J, et al: Predictors of prolonged dysphagia following acute stroke. J Clin Neurosci 2003;10:300-305.
60.
Dziedzic T, Pera J, Klimkowicz A, et al: Serum albumin level and nosocomial pneumonia in stroke patients. Eur J Neurol 2006;13:299-301.
61.
Dziedzic T, Slowik A, Pera J, Szczudlik A: Association between hyperglycemia, heart failure and mortality in stroke patients. Eur J Neurol 2009;16:251-256.
62.
Gosney M, Martin MV, Wright AE: The role of selective decontamination of the digestive tract in acute stroke. Age Ageing 2006;35:42-47.
63.
Ickenstein GW, Riecker A, Hohlig C, et al: Pneumonia and in-hospital mortality in the context of neurogenic oropharyngeal dysphagia (NOD) in stroke and a new NOD step-wise concept. J Neurol 2010;257:1492-1499.
64.
Ifejika-Jones NL, Arun N, Peng H, Elizabeth A, Grotta JC, Francisco GE: The interaction of aspiration pneumonia with demographic and cerebrovascular disease risk factors is predictive of discharge level of care in acute stroke patient. Am J Phys Med Rehabil 2012;91:141-147.
65.
Ingeman A, Andersen G, Hundborg HH, Svendsen ML, Johnsen SP: Processes of care and medical complications in patients with stroke. Stroke 2011;42:167-172.
66.
Minnerup J, Wersching H, Brokinkel B, et al: The impact of lesion location and lesion size on poststroke infection frequency. J Neurol Neurosurg Psychiatry 2010;81:198-202.
67.
Saposnik G, Black SE, Hakim A, et al: Age disparities in stroke quality of care and delivery of health services. Stroke 2009;40:3328-3335.
68.
Aslanyan S, Weir CJ, Diener HC, Kaste M, Lees KR: Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur J Neurol 2004;11:49-53.
69.
Chen CM, Hsu HC, Tsai WS, Chang CH, Chen KH, Hong CZ: Infections in acute older stroke inpatients undergoing rehabilitation. Am J Phys Med Rehabil 2012;91:211-219.
70.
Chumbler NR, Williams LS, Wells CK, et al: Derivation and validation of a clinical system for predicting pneumonia in acute stroke. Neuroepidemiology 2010;34:193-199.
71.
Cuesy PG, Sotomayor PL, Pina JO: Reduction in the incidence of poststroke nosocomial pneumonia by using the ‘turn-mob' program. J Stroke Cerebrovasc Dis 2010;19:23-28.
72.
Field TS, Green TL, Roy K, Pedersen J, Hill MD: Trends in hospital admission for stroke in Calgary. Can J Neurol Sci 2004;31:387-393.
73.
Finlayson O, Kapral M, Hall R, et al: Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke. Neurology 2011;77:1338-1345.
74.
Grau AJ, Buggle F, Schnitzler P, Spiel M, Lichy C, Hacke W: Fever and infection early after ischemic stroke. J Neurol Sci 1999;171:115-120.
75.
Hamidon BB, Raymond AA, Norlinah MI, Jefferelli SB: The predictors of early infection after an acute ischaemic stroke. Singapore Med J 2003;44:344-346.
76.
Hinchey JA, Shephard T, Furie K, Smith D, Wang D, Tonn S: Formal dysphagia screening protocols prevent pneumonia. Stroke 2005;36:1972-1976.
77.
Hong KS, Kang DW, Koo JS, et al: Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke. Eur J Neurol 2008;15:1324-1331.
78.
Johnston KC, Li JY, Lyden PD, et al: Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. Stroke 1998;29:447-453.
79.
Jones EM, Albright KC, Fossati-Bellani M, Siegler JE, Martin-Schild S: Emergency department shift change is associated with pneumonia in patients with acute ischemic stroke. Stroke 2011;42:3226-3230.
80.
Katzan IL, Cebul RD, Husak SH, Dawson NV, Baker DW: The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology 2003;60:620-625.
81.
Ota K, Saitoh E, Baba M, Sonoda S: The secretion severity rating scale: a potentially useful tool for management of acute-phase fasting stroke patients. J Stroke Cerebrovasc Dis 2011;20:183-187.
82.
Sellars C, Bowie L, Bagg J, et al: Risk factors for chest infection in acute stroke: a prospective cohort study. Stroke 2007;38:2284-2291.
83.
Hanchaiphiboolkul S: Risk factors for early infection after an acute cerebral infarction. J Med Assoc of Thai 2005;88:150-155.
84.
Kolb G, Broker M: State of the art in aspiration assessment and the idea of a new non invasive predictive test for the risk of aspiration in stroke. J Nutrition Health Aging 2009;13:429-433.
85.
Falsetti P, Acciai C, Palilla R, et al: Oropharyngeal dysphagia after stroke: incidence, diagnosis, and clinical predictors in patients admitted to a neurorehabilitation unit. J Stroke Cerebrovasc Dis 2009;18:329-335.
86.
Lipson DM, Sangha H, Foley NC, Bhogal S, Pohani G, Teasell RW: Recovery from stroke: differences between subtypes. Int J Rehabil Res 2005;28:303-308.
87.
Teasell R, Foley N, Doherty T, Finestone H: Clinical characteristics of patients with brainstem strokes admitted to a rehabilitation unit. Arch Phys Med Rehabil 2002;83:1013-1016.
88.
Seo WK, Yu SW, Kim JH, Park KW, Koh SB: The impact of hyperthermia and infection on acute ischemic stroke patients in the intensive care unit. Neurocrit Care 2008;9:183-188.
89.
Adams HP Jr, del Zoppo G, Alberts MJ, et al: Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 2007;115:e478-e534.
90.
Gomes CA Jr, Lustosa SA, Matos D, Andriolo RB, Waisberg DR, Waisberg J: Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances. Cochrane Database Syst Rev 2012;3:CD008096.
91.
Meisel C, Prass K, Braun J, et al: Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke. Stroke 2004;35:2-6.
92.
Harms H, Prass K, Meisel C, et al: Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PLoS One 2008;3:e2158.
93.
Chamorro A, Horcajada JP, Obach V, et al: The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial. Stroke 2005;36:1495-1500.
94.
Schwarz S, Al-Shajlawi F, Sick C, Meairs S, Hennerici MG: Effects of prophylactic antibiotic therapy with mezlocillin plus sulbactam on the incidence and height of fever after severe acute ischemic stroke: the Mannheim infection in stroke study (MISS). Stroke 2008;39:1220-1227.
95.
Westendorp WF, Vermeij JD, Vermeij F, et al: Antibiotic therapy for preventing infections in patients with acute stroke. Cochrane Database Syst Rev 2012;1:CD008530.
96.
Nederkoorn PJ, Westendorp WF, Hooijenga IJ, et al: Preventive antibiotics in stroke study: rationale and protocol for a randomised trial. Int J Stroke 2011;6:159-163.
97.
Braun JS, Prass K, Dirnagl U, Meisel A, Meisel C: Protection from brain damage and bacterial infection in murine stroke by the novel caspase-inhibitor Q-VD-OPH. Exp Neurol 2007;206:183-191.
98.
Shinohara Y: Antiplatelet cilostazol is effective in the prevention of pneumonia in ischemic stroke patients in the chronic stage. Cerebrovasc Dis 2006;22:57-60.
99.
Ohkubo T, Chapman N, Neal B, et al: Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk. Am J Respir Crit Care Med 2004;169:1041-1045.
100.
Shinohara Y, Origasa H: Post-stroke pneumonia prevention by angiotensin-converting enzyme inhibitors: results of a meta-analysis of five studies in Asians. Adv Ther 2012;29:900-912.
101.
Torres A, Ferrer M, Badia JR: Treatment guidelines and outcomes of hospital-acquired and ventilator-associated pneumonia. Clin Infect Dis 2010;51(suppl 1):S48-S53.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.